Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of 3Analytics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
3Analytics is a technology company that provides AI-driven, GxP-compliant software platforms designed to enhance patient safety and regulatory compliance in the drug, vaccine, and medical device sectors. Their solutions leverage AI, machine learning, and natural language processing to automate pharmacovigilance tasks such as literature surveillance, signal management, IMDRF coding, and complaint processing. The company focuses on transforming reactive compliance into proactive safety management by integrating data from various sources, including real-world evidence and regulatory databases. They serve global clients in the life sciences industry, aiming to reduce manual effort, minimize human error, and ensure adherence to international regulatory standards.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Pharmacovigilance & Regulatory Tech
SIZE & FINANCIALS
Employees:51-200
Revenue:$0.25M-$1M
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$0.48M
Investors:Angel Investors
0
CORPORATE STRUCTURE
Subsidiaries:3ANALYTICS INDIA PRIVATE LIMITED
Key Partnerships:AssurX (Partnership for IMDRF coding and quality management solutions)
COMPETITION
Position:Emerging
Competitors:Greenlight Guru, MasterControl, Enzyme
LEADERSHIP
Key Executives:
Dr. Dharani Munirathinam - CEO, Co-founder
Scientific Founders:Dr. Dharani Munirathinam
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with 3Analytics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.